If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mario Salvi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Teprotumumab for the treatment of active thyroid eye disease

Douglas, R. S., Kahaly, G. J., Patel, A., Sile, S., Thompson, E. H. Z., Perdok, R., Fleming, J. C., Fowler, B. T., Marcocci, C., Marinò, M., Antonelli, A., Dailey, R., Harris, G. J., Eckstein, A., Schiffman, J., Tang, R., Nelson, C., Salvi, M., Wester, S., Sherman, J. W. & 3 others, Vescio, T., Holt, R. J. & Smith, T. J., Jan 23 2020, In : New England Journal of Medicine. 382, 4, p. 341-352 12 p.

Research output: Contribution to journalArticle

  • B cells in Graves’ Orbitopathy: more than just a source of antibodies?

    Salvi, M. & Covelli, D., 2019, In : Eye (Basingstoke). 33, 2, p. 230-234

    Research output: Contribution to journalArticle

  • Combined immunosuppressants and less steroids in active graves' orbitopathy?

    Salvi, M. & Covelli, D., Apr 1 2019, In : Clinical Endocrinology. 90, 4, p. 525-527 3 p.

    Research output: Contribution to journalComment/debate